1
Enquiry period
with 04.06.2026 10:22
to 08.06.2026 12:00
2
Bidding period
with 08.06.2026 12:00
to 12.06.2026 12:00
3
Auction
with 15.06.2026 09:00
to 15.06.2026 12:56
4
Evaluation

5
Contract

Status Evaluation
Estimated value without VAT 560 492,08 MDL
Period of clarifications: 4 Jun 2026, 10:22 - 8 Jun 2026, 12:00
Submission of proposals: 8 Jun 2026, 12:00 - 12 Jun 2026, 12:00

Supplier technical support:

(+373) 79999801

Advertising
Advertising

“Achiziționarea medicamentelor necesare instituțiilor medico-sanitare publice (IMSP) și instituțiilor bugetare care prestează servicii medicale și sociale pentru anul 2026 (suplimentar nr. 8)”

Information about customer
Fiscal code/IDNO
Address
MD-2005, MOLDOVA, mun.Chişinău, locality, mun. Chișinău MD-2005, bd. Grigore Vieru, 22/2
Web site
---
The contact person
Full name
Potînga Radu
Contact phone
+37322222490
Purchase data
Date created
4 Jun 2026, 10:16
Date modified
4 Jun 2026, 10:22
Achizitii.md ID
21628035
CPV
33600000-6 - Produse farmaceutice
Type of procedure
Request price offers (goods)
Award criteria
The lowest price
Funding sources
List of lots
Purchase has not taken place
Purchase has not taken place
Lot nr. 5 - Amikacinum 1000 mg
Budget: 3425.36 MDL
Purchase has not taken place
Purchase has not taken place
Lot nr. 7 - Aripiprazolum 10 mg
Budget: 13016.0 MDL
Active
Purchase has not taken place
Lot nr. 9 - Bisoprololum 5 mg
Budget: 696.27 MDL
Active
Purchase has not taken place
Lot nr. 14 - Ceftriaxonum 1000 mg
Budget: 10291.33 MDL
Purchase has not taken place
Purchase has not taken place
Purchase has not taken place
Purchase has not taken place
Purchase has not taken place
Purchase has not taken place
Purchase has not taken place
Lot nr. 26 - Glucosum 40%
Budget: 115114.04 MDL
Active
Purchase has not taken place
Purchase has not taken place
Purchase has not taken place
Lot nr. 33 - Memantinum 10 mg
Budget: 8849.26 MDL
Active
Lot nr. 35 - Metoprololum 25 mg
Budget: 1757.44 MDL
Purchase has not taken place
Lot nr. 36 - Morphinum 1% 1 ml
Budget: 296.0 MDL
Purchase has not taken place
Purchase has not taken place
Purchase has not taken place
Lot nr. 40 - Nifedipinum 10 mg
Budget: 2562.0 MDL
Purchase has not taken place
Lot nr. 41 - Nifedipinum 20 mg
Budget: 3797.55 MDL
Purchase has not taken place
Purchase has not taken place
Purchase has not taken place
Purchase has not taken place
Lot nr. 46 - Pantoprazolum 40 mg
Budget: 151803.0 MDL
Active
Purchase has not taken place
Purchase has not taken place
Lot nr. 50 - Piracetamum 400 mg
Budget: 13870.8 MDL
Purchase has not taken place
Purchase has not taken place
Lot nr. 53 - Pregabalinum 75 mg
Budget: 707.77 MDL
Purchase has not taken place
Lot nr. 57 - Sulpiridum 200 mg
Budget: 4588.65 MDL
Purchase has not taken place
Purchase has not taken place
Lot nr. 60 - Ticagrelorum 90 mg
Budget: 24179.45 MDL
Active
Purchase has not taken place
Purchase has not taken place
Purchase has not taken place
Lot nr. 65 - Zopiclonum 7.5 mg
Budget: 2326.77 MDL
Purchase has not taken place
Advertising
Documents of the procurement procedure
Lista de distributie LS 8
Bidding Documents
Lista de distributie LS 8
4.06.26 10:22
Scrisoare de garantie bancara_Model
Bidding Documents
Scrisoare de garantie bancara_Model
4.06.26 10:22
Cerere de participare_Model
Bidding Documents
Cerere de participare_Model
4.06.26 10:22
Documentatia standard LS 8.signed
Bidding Documents
Documentatia standard LS 8.signed
4.06.26 10:22
Declaratie privind valabilitatea ofertei_Model
Bidding Documents
Declaratie privind valabilitatea ofertei_Model
4.06.26 10:22
Model de contract
Bidding Documents
Model de contract
4.06.26 10:22
DUAE Model
Bidding Documents
DUAE Model
4.06.26 10:22
Propunerea tehnică
Technical Specifications
Propunerea tehnică
4.06.26 10:22
Anunt de participare LS 8.signed
Bidding Documents
Anunt de participare LS 8.signed
4.06.26 10:22
Declaratie beneficiari efectivi_Model
Bidding Documents
Declaratie beneficiari efectivi_Model
4.06.26 10:22
Propunerea financiară
Technical Specifications
Propunerea financiară
4.06.26 10:22
Only authorized platform users may ask questions during the clarification period.